(Q24648007)

25 April 2019

20 August 2019

12 September 2019

20 November 2019

15 December 2019

on focus list of Wikimedia project

29 April 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Neuropathological stageing of Alzheimer-related changes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

A beta oligomers - a decade of discovery

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

The Clinical Dementia Rating (CDR): current version and scoring rules

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons

7 April 2017

1 reference

12 December 2020

Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication

1 reference

12 December 2020

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

1 reference

12 December 2020

Amyloid imaging in Alzheimer's disease.

1 reference

12 December 2020

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

1 reference

12 December 2020

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

1 reference

12 December 2020

Will anti-amyloid therapies work for Alzheimer's disease?

1 reference

12 December 2020

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

1 reference

12 December 2020

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease

1 reference

12 December 2020

PET imaging of amyloid deposition in patients with mild cognitive impairment.

1 reference

12 December 2020

Imaging amyloid deposition in Lewy body diseases

1 reference

12 December 2020

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

1 reference

12 December 2020

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

1 reference

12 December 2020

PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment

1 reference

12 December 2020

The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation

1 reference

12 December 2020

Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation.

1 reference

12 December 2020

Frequent amyloid deposition without significant cognitive impairment among the elderly

1 reference

12 December 2020

Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia

1 reference

12 December 2020

Primary progressive aphasia and the growing role of biomarkers in neurological diagnosis

1 reference

12 December 2020

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

1 reference

12 December 2020

Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B

1 reference

12 December 2020

Characterization of PiB binding to white matter in Alzheimer disease and other dementias

1 reference

12 December 2020

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

1 reference

12 December 2020

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

1 reference

12 December 2020

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics

1 reference

12 December 2020

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies

1 reference

12 December 2020

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

1 reference

12 December 2020

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

1 reference

12 December 2020

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

1 reference

12 December 2020

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

1 reference

12 December 2020

Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid

1 reference

12 December 2020

11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.

1 reference

12 December 2020

Clinical severity of Alzheimer's disease is associated with PIB uptake in PET.

1 reference

12 December 2020

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

1 reference

12 December 2020

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

1 reference

12 December 2020

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease

1 reference

12 December 2020

In vivo amyloid imaging with PET in frontotemporal dementia.

1 reference

12 December 2020

Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

1 reference

12 December 2020

Absence of cognitive impairment or decline in preclinical Alzheimer's disease.

1 reference

12 December 2020

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

12 December 2020

Regional dendritic and spine variation in human cerebral cortex: a quantitative golgi study

1 reference

12 December 2020

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease

1 reference

12 December 2020

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease

1 reference

12 December 2020

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

1 reference

12 December 2020

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

1 reference

12 December 2020

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile

1 reference

12 December 2020

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

1 reference

12 December 2020

Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment

1 reference

12 December 2020

Molecular-imaging probe 2-(1-[6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene) malononitrile labels prion plaques in vitro.

1 reference

12 December 2020

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice

1 reference

12 December 2020

PET imaging of amyloid in Alzheimer's disease.

1 reference

12 December 2020

Plaques, tangles and dementia. A quantitative study.

1 reference

12 December 2020

Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes

1 reference

12 December 2020

Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease

1 reference

12 December 2020

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

1 reference

12 December 2020

The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease.

1 reference

12 December 2020

Neuroimaging of vessel amyloid in Alzheimer's disease.

1 reference

12 December 2020

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

12 December 2020

Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study

1 reference

12 December 2020

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

1 reference

12 December 2020

Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.

1 reference

12 December 2020

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

12 December 2020

Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy

1 reference

12 December 2020

In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.

1 reference

12 December 2020

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

1 reference

12 December 2020

Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

1 reference

12 December 2020

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis

1 reference

12 December 2020

Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease

1 reference

12 December 2020

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

12 December 2020

Neuropathology of older persons without cognitive impairment from two community-based studies

1 reference

12 December 2020

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

12 December 2020

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

1 reference

12 December 2020

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.

1 reference

12 December 2020

PET of brain amyloid and tau in mild cognitive impairment.

1 reference

12 December 2020

Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.

1 reference

12 December 2020

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

1 reference

12 December 2020

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

1 reference

12 December 2020

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.

1 reference

12 December 2020

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.

1 reference

12 December 2020

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.

1 reference

12 December 2020

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

1 reference

12 December 2020

Imaging beta-amyloid burden in aging and dementia.

1 reference

12 December 2020

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

1 reference

12 December 2020

Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease

1 reference

12 December 2020

Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.

1 reference

12 December 2020

PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis

1 reference

12 December 2020

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

1 reference

12 December 2020

Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.

1 reference

12 December 2020

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

1 reference

12 December 2020

Identifiers

DOI

10.3233/BEN-2009-0232

1 reference

10.1155/2009/609839

1 reference

1 reference

1 reference

PubMed publication ID

19847050

1 reference